S.Biomedics Co., Ltd.
Research S.Biomedics Co., Ltd. (304360.KQ) on Bullrun: market cap KRW 260.71B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker304360.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 260.71B
- Financial periodQ2 2026
- RevenueKRW 4.82B
- Net income-KRW 6.84B
- Free cash flow-KRW 3.49B
- Gross margin47.9%
Valuation Snapshot
latest market cap is KRW 260.71B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 260.71B | n/a | n/a | n/a |
Dividend history
About S.Biomedics Co., Ltd.
S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products. Its product pipeline comprises TED-N, which is in phase 1/2a clinical development for the treatment of subacute spinal cord injury; TED-A9, which is in phase 1/2a clinical development for the treatment of parkinson's disease; FECS-Ad, which is 1/2a for the treatment of critical limb ischemia; FECS-DF, which is in phase 1/2 clinical development for the treatment of crows feet;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is S.Biomedics Co., Ltd.'s market cap?
S.Biomedics Co., Ltd.'s market capitalization is KRW 260.71B.
What does S.Biomedics Co., Ltd. do?
S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.